Abstract
SELDI-TOF and depletion of major blood proteins is one of the most promising approaches for accessing low-abundance biomarkers. The use of combinatorial peptide ligand library (CPLL) for selecting the low-abundance proteins and of liquid-phase isoelectric focusing for purifying the corresponding proteins was tested in plasma or serum from patients with myocardial infarction (MI).
Here, we describe the SELDI profiling of CPLL-treated plasma to select low-abundance proteins in plasma and the strategy for purification and mass spectrometry identification. This approach shows the potential to select and identify candidate biomarkers in patients with left ventricular remodeling after MI.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dubois E, Fertin M, Burdese J et al (2011) Cardiovascular proteomics: translational studies to develop novel biomarkers in heart failure and left ventricular remodeling. Proteomics Clin Appl 5:57–66
Reddy G, Dalmasso EA (2003) SELDI ProteinChip® array technology: protein-based predictive medicine and drug discovery applications. J Biomed Biotechnol 2003:237–241
Issaq HJ, Conrads TP, Prieto DA et al (2003) SELDI-TOF MS for diagnostic proteomics. Anal Chem 75:148A–155A
Savoye C, Equine O, Tricot O et al (2006) Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the Remodelage VEntriculaire (REVE) study group). Am J Cardiol 98:1144–1149
Pinet F, Beseme O, Cieniewski-Bernard C et al (2008) Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis. Proteomics 8:1798–17808
Anderson NL, Polanski M, Pieper R et al (2004) The human plasma proteome: a non redundant list developed by combination of four separate sources. Mol Cell Proteomics 3:311–326
Righetti PG, Boschetti E, Lomas L et al (2006) Protein equalizer technology: the quest for a “democratic proteome”. Proteomics 6:3980–3992
Fertin M, Beseme O, Duban S et al (2010) Deep plasma proteomic analysis of patients with left ventricular remodeling after a first myocardial infarction. Proteomics Clin Appl 4:654–673
Beseme O, Fertin M, Drobecq H et al (2010) Combinatorial peptide ligand library plasma treatment: advantages for accessing low-abundance proteins. Electrophoresis 31:2697–2704
Hey J, Posch A, Cohen A et al (2008) Fractionation of complex protein mixtures by liquid-phase isoelectric focusing. Methods Mol Biol 424:225–2239
Fertin M, Burdese J, Beseme O et al (2011) Strategy for purification and mass spectrometry identification of SELDI peaks corresponding to low-abundance plasma and serum proteins. J Proteomics 74:420–430
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Pinet, F. (2013). Proteomic Analysis of Plasma of Patients with Left Ventricular Remodeling After Myocardial Infarction: Usefulness of SELDI-TOF. In: Vivanco, F. (eds) Vascular Proteomics. Methods in Molecular Biology, vol 1000. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-405-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-62703-405-0_15
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-404-3
Online ISBN: 978-1-62703-405-0
eBook Packages: Springer Protocols